Biotech - Technical Analysis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech - Technical Analysis

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (495)	7/19/2002 11:51:22 AM
From: Jibacoa	of 544

SGMO Is performing fairly well today (Taking into account the general market.<g>) It announced on Tuesday a collaboration with Icagen which will be using SGMO's zinc finger DNA binding protein transcription factor (ZFP-TF) technology platform.(They have previous similar deals with JNJ & Pharmacia) Using a specific ZFP TF, a cell line can be engineered that will effect over-expression of a protein that has been implicated in a specific disease, and that should enable pharmaceutical researchers to more quickly assess the impact of various chemical compounds on that target. The insiders reportedly hold close to 70% of the shares and institutions 28% (about 93% of the float.<g>)(The float is only 7.5M) SGMO reportedly has $2.40 cash/share and last Q loss was $0.18 (Next earnings report is due on Wednesday)It has a Current Ratio > 33 The stock seems to have good support at the 3.90 level. siliconinvestor.com It is going to look much better on a close above 6.50 <g> siliconinvestor.com siliconinvestor.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next